Advances in Phage Therapy as a Treatment for Cystic Fibrosis - Benjamin Chan, PhD; Jon Koff, MD (Audio)

Dr. Benjamin Chan, an Associate Research Scientist in the Department of Ecology and Evolutionary Biology at Yale University, and Dr. Jon Koff, Director of the Adult Cystic Fibrosis Program at Yale University, give a comprehensive overview on recent progress in phage therapy as a treatment for CF, including the development of a clinical trial to investigate the safety and efficacy of a nebulized personalized phage therapy approach and the establishment of a Center for Bacteriophage Research and Therapy at Yale. This presentation was part of CFRI's Virtual 34th National CF Education Conference on July 31, 2021.

CFRI's 34th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.